nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—PTGS1—Ifosfamide—testicular cancer	0.261	0.353	CbGbCtD
Zileuton—PTGS1—Etoposide—testicular cancer	0.125	0.168	CbGbCtD
Zileuton—CYP2C9—Ifosfamide—testicular cancer	0.105	0.142	CbGbCtD
Zileuton—CYP3A4—Ifosfamide—testicular cancer	0.0611	0.0825	CbGbCtD
Zileuton—CYP1A2—Etoposide—testicular cancer	0.0558	0.0753	CbGbCtD
Zileuton—CYP2C9—Cisplatin—testicular cancer	0.0511	0.069	CbGbCtD
Zileuton—CYP3A4—Vinblastine—testicular cancer	0.0324	0.0438	CbGbCtD
Zileuton—CYP3A4—Etoposide—testicular cancer	0.0292	0.0394	CbGbCtD
Zileuton—CYP3A4—Doxorubicin—testicular cancer	0.0199	0.0269	CbGbCtD
Zileuton—Chronic liver disease—Methotrexate—testicular cancer	0.0187	0.0828	CcSEcCtD
Zileuton—EPHX2—seminal vesicle—testicular cancer	0.00568	0.167	CbGeAlD
Zileuton—Hepatotoxicity—Chlorambucil—testicular cancer	0.00556	0.0247	CcSEcCtD
Zileuton—LTB4R—female gonad—testicular cancer	0.00454	0.133	CbGeAlD
Zileuton—LTB4R—testis—testicular cancer	0.00402	0.118	CbGeAlD
Zileuton—Hepatotoxicity—Dactinomycin—testicular cancer	0.00401	0.0178	CcSEcCtD
Zileuton—Hepatotoxicity—Ifosfamide—testicular cancer	0.00368	0.0163	CcSEcCtD
Zileuton—Lymphadenopathy—Chlorambucil—testicular cancer	0.00365	0.0162	CcSEcCtD
Zileuton—EPHX2—female gonad—testicular cancer	0.00334	0.098	CbGeAlD
Zileuton—Hepatotoxicity—Cisplatin—testicular cancer	0.00317	0.0141	CcSEcCtD
Zileuton—EPHX2—testis—testicular cancer	0.00296	0.0869	CbGeAlD
Zileuton—LTB4R—lymph node—testicular cancer	0.00292	0.0856	CbGeAlD
Zileuton—Liver injury—Cisplatin—testicular cancer	0.00291	0.0129	CcSEcCtD
Zileuton—Hepatotoxicity—Etoposide—testicular cancer	0.00291	0.0129	CcSEcCtD
Zileuton—Pain—Carboplatin—testicular cancer	0.00255	0.0113	CcSEcCtD
Zileuton—Body temperature increased—Carboplatin—testicular cancer	0.00235	0.0105	CcSEcCtD
Zileuton—Jaundice—Chlorambucil—testicular cancer	0.00234	0.0104	CcSEcCtD
Zileuton—EPHX2—lymph node—testicular cancer	0.00215	0.063	CbGeAlD
Zileuton—ALOX5—female gonad—testicular cancer	0.002	0.0587	CbGeAlD
Zileuton—Liver disorder—Methotrexate—testicular cancer	0.00197	0.00875	CcSEcCtD
Zileuton—ALOX5—testis—testicular cancer	0.00177	0.0521	CbGeAlD
Zileuton—Hepatotoxicity—Methotrexate—testicular cancer	0.00174	0.00773	CcSEcCtD
Zileuton—Ill-defined disorder—Vinblastine—testicular cancer	0.0016	0.00709	CcSEcCtD
Zileuton—Hepatitis—Dactinomycin—testicular cancer	0.00156	0.00691	CcSEcCtD
Zileuton—Malaise—Vinblastine—testicular cancer	0.00155	0.00689	CcSEcCtD
Zileuton—Conjunctivitis—Ifosfamide—testicular cancer	0.00154	0.00686	CcSEcCtD
Zileuton—Liver injury—Epirubicin—testicular cancer	0.00149	0.00663	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Methotrexate—testicular cancer	0.00148	0.00656	CcSEcCtD
Zileuton—Discomfort—Vinblastine—testicular cancer	0.00145	0.00642	CcSEcCtD
Zileuton—Hepatitis—Ifosfamide—testicular cancer	0.00143	0.00633	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Epirubicin—testicular cancer	0.00138	0.00614	CcSEcCtD
Zileuton—Liver injury—Doxorubicin—testicular cancer	0.00138	0.00614	CcSEcCtD
Zileuton—PTGS1—seminal vesicle—testicular cancer	0.00137	0.0401	CbGeAlD
Zileuton—Dyspepsia—Chlorambucil—testicular cancer	0.00135	0.00599	CcSEcCtD
Zileuton—Ill-defined disorder—Bleomycin—testicular cancer	0.00135	0.00598	CcSEcCtD
Zileuton—Vaginal inflammation—Methotrexate—testicular cancer	0.00134	0.00597	CcSEcCtD
Zileuton—Conjunctivitis—Cisplatin—testicular cancer	0.00133	0.00591	CcSEcCtD
Zileuton—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00132	0.00587	CcSEcCtD
Zileuton—Malaise—Bleomycin—testicular cancer	0.00131	0.00582	CcSEcCtD
Zileuton—Pain—Chlorambucil—testicular cancer	0.00131	0.00582	CcSEcCtD
Zileuton—ALOX5—lymph node—testicular cancer	0.00129	0.0377	CbGeAlD
Zileuton—Hyperbilirubinaemia—Doxorubicin—testicular cancer	0.00128	0.00568	CcSEcCtD
Zileuton—Neck pain—Epirubicin—testicular cancer	0.00127	0.00565	CcSEcCtD
Zileuton—Vaginal infection—Methotrexate—testicular cancer	0.00127	0.00563	CcSEcCtD
Zileuton—Feeling abnormal—Chlorambucil—testicular cancer	0.00126	0.00561	CcSEcCtD
Zileuton—Vaginal inflammation—Epirubicin—testicular cancer	0.00126	0.00558	CcSEcCtD
Zileuton—Ill-defined disorder—Dactinomycin—testicular cancer	0.00126	0.00558	CcSEcCtD
Zileuton—Myalgia—Bleomycin—testicular cancer	0.00124	0.00549	CcSEcCtD
Zileuton—Chest pain—Bleomycin—testicular cancer	0.00124	0.00549	CcSEcCtD
Zileuton—Jaundice—Etoposide—testicular cancer	0.00122	0.00543	CcSEcCtD
Zileuton—Discomfort—Bleomycin—testicular cancer	0.00122	0.00543	CcSEcCtD
Zileuton—Malaise—Dactinomycin—testicular cancer	0.00122	0.00542	CcSEcCtD
Zileuton—Urticaria—Chlorambucil—testicular cancer	0.00122	0.0054	CcSEcCtD
Zileuton—Body temperature increased—Chlorambucil—testicular cancer	0.00121	0.00538	CcSEcCtD
Zileuton—Pain—Vinblastine—testicular cancer	0.0012	0.00533	CcSEcCtD
Zileuton—Constipation—Vinblastine—testicular cancer	0.0012	0.00533	CcSEcCtD
Zileuton—Vaginal infection—Epirubicin—testicular cancer	0.00119	0.00527	CcSEcCtD
Zileuton—Neck pain—Doxorubicin—testicular cancer	0.00118	0.00523	CcSEcCtD
Zileuton—Vaginal inflammation—Doxorubicin—testicular cancer	0.00116	0.00517	CcSEcCtD
Zileuton—Feeling abnormal—Vinblastine—testicular cancer	0.00116	0.00514	CcSEcCtD
Zileuton—Myalgia—Dactinomycin—testicular cancer	0.00115	0.00512	CcSEcCtD
Zileuton—Ill-defined disorder—Ifosfamide—testicular cancer	0.00115	0.00511	CcSEcCtD
Zileuton—Lymphadenopathy—Methotrexate—testicular cancer	0.00114	0.00508	CcSEcCtD
Zileuton—Discomfort—Dactinomycin—testicular cancer	0.00114	0.00506	CcSEcCtD
Zileuton—Hypersensitivity—Chlorambucil—testicular cancer	0.00113	0.00501	CcSEcCtD
Zileuton—Malaise—Ifosfamide—testicular cancer	0.00112	0.00497	CcSEcCtD
Zileuton—Hypertonia—Epirubicin—testicular cancer	0.0011	0.00489	CcSEcCtD
Zileuton—Vaginal infection—Doxorubicin—testicular cancer	0.0011	0.00488	CcSEcCtD
Zileuton—Pruritus—Chlorambucil—testicular cancer	0.00108	0.00481	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00108	0.0048	CcSEcCtD
Zileuton—Lymphadenopathy—Epirubicin—testicular cancer	0.00107	0.00475	CcSEcCtD
Zileuton—Myalgia—Ifosfamide—testicular cancer	0.00106	0.00469	CcSEcCtD
Zileuton—Chest pain—Ifosfamide—testicular cancer	0.00106	0.00469	CcSEcCtD
Zileuton—Arthralgia—Ifosfamide—testicular cancer	0.00106	0.00469	CcSEcCtD
Zileuton—Flatulence—Cisplatin—testicular cancer	0.00105	0.00468	CcSEcCtD
Zileuton—Diarrhoea—Chlorambucil—testicular cancer	0.00105	0.00465	CcSEcCtD
Zileuton—Discomfort—Ifosfamide—testicular cancer	0.00104	0.00464	CcSEcCtD
Zileuton—Hypersensitivity—Vinblastine—testicular cancer	0.00103	0.00459	CcSEcCtD
Zileuton—Hypertonia—Doxorubicin—testicular cancer	0.00102	0.00453	CcSEcCtD
Zileuton—Pain—Bleomycin—testicular cancer	0.00101	0.0045	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00101	0.00447	CcSEcCtD
Zileuton—Ill-defined disorder—Cisplatin—testicular cancer	0.000993	0.00441	CcSEcCtD
Zileuton—Lymphadenopathy—Doxorubicin—testicular cancer	0.00099	0.0044	CcSEcCtD
Zileuton—Feeling abnormal—Bleomycin—testicular cancer	0.000977	0.00434	CcSEcCtD
Zileuton—Vomiting—Chlorambucil—testicular cancer	0.000974	0.00432	CcSEcCtD
Zileuton—Malaise—Cisplatin—testicular cancer	0.000965	0.00429	CcSEcCtD
Zileuton—Diarrhoea—Vinblastine—testicular cancer	0.000961	0.00426	CcSEcCtD
Zileuton—Pain—Dactinomycin—testicular cancer	0.000946	0.0042	CcSEcCtD
Zileuton—Urticaria—Bleomycin—testicular cancer	0.000942	0.00418	CcSEcCtD
Zileuton—Body temperature increased—Bleomycin—testicular cancer	0.000937	0.00416	CcSEcCtD
Zileuton—Dizziness—Vinblastine—testicular cancer	0.000929	0.00412	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000923	0.0041	CcSEcCtD
Zileuton—Myalgia—Cisplatin—testicular cancer	0.000911	0.00405	CcSEcCtD
Zileuton—Feeling abnormal—Dactinomycin—testicular cancer	0.000911	0.00405	CcSEcCtD
Zileuton—Nausea—Chlorambucil—testicular cancer	0.00091	0.00404	CcSEcCtD
Zileuton—Ill-defined disorder—Etoposide—testicular cancer	0.00091	0.00404	CcSEcCtD
Zileuton—Somnolence—Ifosfamide—testicular cancer	0.000901	0.004	CcSEcCtD
Zileuton—Discomfort—Cisplatin—testicular cancer	0.000901	0.004	CcSEcCtD
Zileuton—Vomiting—Vinblastine—testicular cancer	0.000893	0.00396	CcSEcCtD
Zileuton—Malaise—Etoposide—testicular cancer	0.000884	0.00393	CcSEcCtD
Zileuton—Headache—Vinblastine—testicular cancer	0.00088	0.0039	CcSEcCtD
Zileuton—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000875	0.00388	CcSEcCtD
Zileuton—Body temperature increased—Dactinomycin—testicular cancer	0.000874	0.00388	CcSEcCtD
Zileuton—Hypersensitivity—Bleomycin—testicular cancer	0.000874	0.00388	CcSEcCtD
Zileuton—Constipation—Ifosfamide—testicular cancer	0.000867	0.00385	CcSEcCtD
Zileuton—Pain—Ifosfamide—testicular cancer	0.000867	0.00385	CcSEcCtD
Zileuton—Pruritus—Bleomycin—testicular cancer	0.000839	0.00372	CcSEcCtD
Zileuton—Feeling abnormal—Ifosfamide—testicular cancer	0.000835	0.00371	CcSEcCtD
Zileuton—Chest pain—Etoposide—testicular cancer	0.000835	0.00371	CcSEcCtD
Zileuton—Nausea—Vinblastine—testicular cancer	0.000834	0.0037	CcSEcCtD
Zileuton—Abdominal pain upper—Epirubicin—testicular cancer	0.000834	0.0037	CcSEcCtD
Zileuton—Discomfort—Etoposide—testicular cancer	0.000825	0.00366	CcSEcCtD
Zileuton—Hypersensitivity—Dactinomycin—testicular cancer	0.000815	0.00362	CcSEcCtD
Zileuton—Urticaria—Ifosfamide—testicular cancer	0.000805	0.00357	CcSEcCtD
Zileuton—PTGS1—female gonad—testicular cancer	0.000802	0.0236	CbGeAlD
Zileuton—Body temperature increased—Ifosfamide—testicular cancer	0.000801	0.00356	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000796	0.00353	CcSEcCtD
Zileuton—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000784	0.00348	CcSEcCtD
Zileuton—Abdominal pain upper—Doxorubicin—testicular cancer	0.000772	0.00342	CcSEcCtD
Zileuton—Diarrhoea—Dactinomycin—testicular cancer	0.000757	0.00336	CcSEcCtD
Zileuton—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000754	0.00335	CcSEcCtD
Zileuton—Vomiting—Bleomycin—testicular cancer	0.000754	0.00335	CcSEcCtD
Zileuton—Rash—Bleomycin—testicular cancer	0.000748	0.00332	CcSEcCtD
Zileuton—Pain—Cisplatin—testicular cancer	0.000747	0.00332	CcSEcCtD
Zileuton—Dermatitis—Bleomycin—testicular cancer	0.000747	0.00332	CcSEcCtD
Zileuton—Hypersensitivity—Ifosfamide—testicular cancer	0.000747	0.00331	CcSEcCtD
Zileuton—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000733	0.00326	CcSEcCtD
Zileuton—Conjunctivitis—Methotrexate—testicular cancer	0.000731	0.00324	CcSEcCtD
Zileuton—Feeling abnormal—Cisplatin—testicular cancer	0.00072	0.0032	CcSEcCtD
Zileuton—Pruritus—Ifosfamide—testicular cancer	0.000717	0.00318	CcSEcCtD
Zileuton—PTGS1—testis—testicular cancer	0.000712	0.0209	CbGeAlD
Zileuton—Somnolence—Etoposide—testicular cancer	0.000712	0.00316	CcSEcCtD
Zileuton—Nausea—Bleomycin—testicular cancer	0.000704	0.00313	CcSEcCtD
Zileuton—Vomiting—Dactinomycin—testicular cancer	0.000703	0.00312	CcSEcCtD
Zileuton—Rash—Dactinomycin—testicular cancer	0.000697	0.0031	CcSEcCtD
Zileuton—Diarrhoea—Ifosfamide—testicular cancer	0.000693	0.00308	CcSEcCtD
Zileuton—Gastrointestinal disorder—Etoposide—testicular cancer	0.000691	0.00307	CcSEcCtD
Zileuton—Body temperature increased—Cisplatin—testicular cancer	0.000691	0.00307	CcSEcCtD
Zileuton—Jaundice—Epirubicin—testicular cancer	0.000686	0.00304	CcSEcCtD
Zileuton—Pain—Etoposide—testicular cancer	0.000685	0.00304	CcSEcCtD
Zileuton—Constipation—Etoposide—testicular cancer	0.000685	0.00304	CcSEcCtD
Zileuton—Conjunctivitis—Epirubicin—testicular cancer	0.000684	0.00304	CcSEcCtD
Zileuton—Urinary tract infection—Epirubicin—testicular cancer	0.000684	0.00304	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000679	0.00301	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—testicular cancer	0.000675	0.003	CcSEcCtD
Zileuton—Dizziness—Ifosfamide—testicular cancer	0.00067	0.00298	CcSEcCtD
Zileuton—Sinusitis—Epirubicin—testicular cancer	0.00066	0.00293	CcSEcCtD
Zileuton—Feeling abnormal—Etoposide—testicular cancer	0.00066	0.00293	CcSEcCtD
Zileuton—Nausea—Dactinomycin—testicular cancer	0.000657	0.00292	CcSEcCtD
Zileuton—Vomiting—Ifosfamide—testicular cancer	0.000644	0.00286	CcSEcCtD
Zileuton—Hypersensitivity—Cisplatin—testicular cancer	0.000644	0.00286	CcSEcCtD
Zileuton—Rash—Ifosfamide—testicular cancer	0.000639	0.00284	CcSEcCtD
Zileuton—Dermatitis—Ifosfamide—testicular cancer	0.000638	0.00283	CcSEcCtD
Zileuton—Urticaria—Etoposide—testicular cancer	0.000636	0.00282	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—testicular cancer	0.000635	0.00282	CcSEcCtD
Zileuton—Body temperature increased—Etoposide—testicular cancer	0.000633	0.00281	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—testicular cancer	0.000633	0.00281	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—testicular cancer	0.000633	0.00281	CcSEcCtD
Zileuton—Hepatitis—Epirubicin—testicular cancer	0.000632	0.0028	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—testicular cancer	0.000611	0.00271	CcSEcCtD
Zileuton—Nausea—Ifosfamide—testicular cancer	0.000602	0.00267	CcSEcCtD
Zileuton—Diarrhoea—Cisplatin—testicular cancer	0.000598	0.00265	CcSEcCtD
Zileuton—Hypersensitivity—Etoposide—testicular cancer	0.00059	0.00262	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—testicular cancer	0.000584	0.00259	CcSEcCtD
Zileuton—Pruritus—Etoposide—testicular cancer	0.000566	0.00251	CcSEcCtD
Zileuton—Vomiting—Cisplatin—testicular cancer	0.000556	0.00247	CcSEcCtD
Zileuton—Rash—Cisplatin—testicular cancer	0.000551	0.00245	CcSEcCtD
Zileuton—Dermatitis—Cisplatin—testicular cancer	0.00055	0.00244	CcSEcCtD
Zileuton—Diarrhoea—Etoposide—testicular cancer	0.000548	0.00243	CcSEcCtD
Zileuton—Ill-defined disorder—Methotrexate—testicular cancer	0.000545	0.00242	CcSEcCtD
Zileuton—Flatulence—Epirubicin—testicular cancer	0.000542	0.0024	CcSEcCtD
Zileuton—Tension—Epirubicin—testicular cancer	0.00054	0.00239	CcSEcCtD
Zileuton—Nervousness—Epirubicin—testicular cancer	0.000534	0.00237	CcSEcCtD
Zileuton—Malaise—Methotrexate—testicular cancer	0.00053	0.00235	CcSEcCtD
Zileuton—Dizziness—Etoposide—testicular cancer	0.000529	0.00235	CcSEcCtD
Zileuton—Nausea—Cisplatin—testicular cancer	0.000519	0.0023	CcSEcCtD
Zileuton—PTGS1—lymph node—testicular cancer	0.000516	0.0152	CbGeAlD
Zileuton—Ill-defined disorder—Epirubicin—testicular cancer	0.00051	0.00226	CcSEcCtD
Zileuton—Vomiting—Etoposide—testicular cancer	0.000509	0.00226	CcSEcCtD
Zileuton—Rash—Etoposide—testicular cancer	0.000505	0.00224	CcSEcCtD
Zileuton—Dermatitis—Etoposide—testicular cancer	0.000504	0.00224	CcSEcCtD
Zileuton—Headache—Etoposide—testicular cancer	0.000501	0.00223	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—testicular cancer	0.000501	0.00223	CcSEcCtD
Zileuton—Chest pain—Methotrexate—testicular cancer	0.0005	0.00222	CcSEcCtD
Zileuton—Myalgia—Methotrexate—testicular cancer	0.0005	0.00222	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—testicular cancer	0.0005	0.00222	CcSEcCtD
Zileuton—Tension—Doxorubicin—testicular cancer	0.000499	0.00222	CcSEcCtD
Zileuton—Malaise—Epirubicin—testicular cancer	0.000496	0.0022	CcSEcCtD
Zileuton—Discomfort—Methotrexate—testicular cancer	0.000494	0.00219	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—testicular cancer	0.000494	0.00219	CcSEcCtD
Zileuton—Nausea—Etoposide—testicular cancer	0.000475	0.00211	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—testicular cancer	0.000472	0.0021	CcSEcCtD
Zileuton—Chest pain—Epirubicin—testicular cancer	0.000468	0.00208	CcSEcCtD
Zileuton—Myalgia—Epirubicin—testicular cancer	0.000468	0.00208	CcSEcCtD
Zileuton—Arthralgia—Epirubicin—testicular cancer	0.000468	0.00208	CcSEcCtD
Zileuton—Discomfort—Epirubicin—testicular cancer	0.000462	0.00205	CcSEcCtD
Zileuton—Malaise—Doxorubicin—testicular cancer	0.000459	0.00204	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000437	0.00194	CcSEcCtD
Zileuton—Insomnia—Methotrexate—testicular cancer	0.000434	0.00193	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—testicular cancer	0.000433	0.00192	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—testicular cancer	0.000433	0.00192	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—testicular cancer	0.000433	0.00192	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—testicular cancer	0.000428	0.0019	CcSEcCtD
Zileuton—Somnolence—Methotrexate—testicular cancer	0.000426	0.00189	CcSEcCtD
Zileuton—Dyspepsia—Methotrexate—testicular cancer	0.000422	0.00187	CcSEcCtD
Zileuton—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000414	0.00184	CcSEcCtD
Zileuton—Pain—Methotrexate—testicular cancer	0.00041	0.00182	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000409	0.00181	CcSEcCtD
Zileuton—Insomnia—Epirubicin—testicular cancer	0.000406	0.0018	CcSEcCtD
Zileuton—Somnolence—Epirubicin—testicular cancer	0.000399	0.00177	CcSEcCtD
Zileuton—Feeling abnormal—Methotrexate—testicular cancer	0.000395	0.00175	CcSEcCtD
Zileuton—Dyspepsia—Epirubicin—testicular cancer	0.000395	0.00175	CcSEcCtD
Zileuton—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000387	0.00172	CcSEcCtD
Zileuton—Constipation—Epirubicin—testicular cancer	0.000384	0.0017	CcSEcCtD
Zileuton—Pain—Epirubicin—testicular cancer	0.000384	0.0017	CcSEcCtD
Zileuton—Urticaria—Methotrexate—testicular cancer	0.000381	0.00169	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—testicular cancer	0.000379	0.00168	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000378	0.00168	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—testicular cancer	0.000376	0.00167	CcSEcCtD
Zileuton—Feeling abnormal—Epirubicin—testicular cancer	0.00037	0.00164	CcSEcCtD
Zileuton—Somnolence—Doxorubicin—testicular cancer	0.000369	0.00164	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—testicular cancer	0.000365	0.00162	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000358	0.00159	CcSEcCtD
Zileuton—Urticaria—Epirubicin—testicular cancer	0.000356	0.00158	CcSEcCtD
Zileuton—Constipation—Doxorubicin—testicular cancer	0.000355	0.00158	CcSEcCtD
Zileuton—Pain—Doxorubicin—testicular cancer	0.000355	0.00158	CcSEcCtD
Zileuton—Body temperature increased—Epirubicin—testicular cancer	0.000355	0.00157	CcSEcCtD
Zileuton—Hypersensitivity—Methotrexate—testicular cancer	0.000353	0.00157	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—testicular cancer	0.000342	0.00152	CcSEcCtD
Zileuton—Pruritus—Methotrexate—testicular cancer	0.000339	0.00151	CcSEcCtD
Zileuton—Hypersensitivity—Epirubicin—testicular cancer	0.000331	0.00147	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—testicular cancer	0.00033	0.00146	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—testicular cancer	0.000328	0.00146	CcSEcCtD
Zileuton—Diarrhoea—Methotrexate—testicular cancer	0.000328	0.00146	CcSEcCtD
Zileuton—Pruritus—Epirubicin—testicular cancer	0.000317	0.00141	CcSEcCtD
Zileuton—Dizziness—Methotrexate—testicular cancer	0.000317	0.00141	CcSEcCtD
Zileuton—Diarrhoea—Epirubicin—testicular cancer	0.000307	0.00136	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—testicular cancer	0.000306	0.00136	CcSEcCtD
Zileuton—Vomiting—Methotrexate—testicular cancer	0.000305	0.00135	CcSEcCtD
Zileuton—Rash—Methotrexate—testicular cancer	0.000302	0.00134	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—testicular cancer	0.000302	0.00134	CcSEcCtD
Zileuton—Headache—Methotrexate—testicular cancer	0.0003	0.00133	CcSEcCtD
Zileuton—Dizziness—Epirubicin—testicular cancer	0.000297	0.00132	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—testicular cancer	0.000294	0.0013	CcSEcCtD
Zileuton—Vomiting—Epirubicin—testicular cancer	0.000285	0.00127	CcSEcCtD
Zileuton—Nausea—Methotrexate—testicular cancer	0.000285	0.00126	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—testicular cancer	0.000284	0.00126	CcSEcCtD
Zileuton—Rash—Epirubicin—testicular cancer	0.000283	0.00126	CcSEcCtD
Zileuton—Dermatitis—Epirubicin—testicular cancer	0.000283	0.00125	CcSEcCtD
Zileuton—Headache—Epirubicin—testicular cancer	0.000281	0.00125	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—testicular cancer	0.000275	0.00122	CcSEcCtD
Zileuton—Nausea—Epirubicin—testicular cancer	0.000267	0.00118	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—testicular cancer	0.000264	0.00117	CcSEcCtD
Zileuton—Rash—Doxorubicin—testicular cancer	0.000262	0.00116	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—testicular cancer	0.000262	0.00116	CcSEcCtD
Zileuton—Headache—Doxorubicin—testicular cancer	0.00026	0.00115	CcSEcCtD
Zileuton—Nausea—Doxorubicin—testicular cancer	0.000247	0.00109	CcSEcCtD
